These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32618475)

  • 1. Minocycline Topical Foam: A New Drug for the Treatment of Acne.
    Onge ES; Mobley WC
    Ann Pharmacother; 2021 Jan; 55(1):105-110. PubMed ID: 32618475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: A phase 3 study.
    Raoof TJ; Hooper D; Moore A; Zaiac M; Sullivan T; Kircik L; Lain E; Jankicevic J; Stuart I
    J Am Acad Dermatol; 2020 Apr; 82(4):832-837. PubMed ID: 31163231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Results of 2 randomized, double-blind, phase 3 studies.
    Gold LS; Dhawan S; Weiss J; Draelos ZD; Ellman H; Stuart IA
    J Am Acad Dermatol; 2019 Jan; 80(1):168-177. PubMed ID: 30165171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
    Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
    Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic Comparison of Once-Daily Topical Minocycline Foam 4% vs Oral Minocycline for Moderate-to-Severe Acne.
    Jones TM; Ellman H; deVries T
    J Drugs Dermatol; 2017 Oct; 16(10):1022-1028. PubMed ID: 29036256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical Minocycline Foam 4%: A Review in Acne Vulgaris.
    Paik J
    Am J Clin Dermatol; 2020 Jun; 21(3):449-456. PubMed ID: 32468355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating FMX-101 as a promising therapeutic for the treatment of acne.
    Valente Duarte de Sousa IC
    Expert Opin Pharmacother; 2020 May; 21(7):741-746. PubMed ID: 32037906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating Acne With Topical Antibiotics: Current Obstacles and the Introduction of Topical Minocycline as a New Treatment Option.
    Bonati LM; Dover JS
    J Drugs Dermatol; 2019 Mar; 18(3):240-244. PubMed ID: 30909327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
    J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady EA; Popescu C; Newton J; Li WA
    Cochrane Database Syst Rev; 2003; (1):CD002086. PubMed ID: 12535427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amzeeq (minocycline foam 4%) for topical treatment of acne vulgaris.
    Gupta AK; Bruce A; Vincent KD; Abramovits W
    Skinmed; 2020; 18(6):354-357. PubMed ID: 33397564
    [No Abstract]   [Full Text] [Related]  

  • 12. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady A; Bennett C; Newton JN; Thomas K; Popescu CM
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002086. PubMed ID: 22895927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical minocycline foam 4%: Results of four phase 1 studies evaluating the potential for phototoxicity, photoallergy, sensitization, and cumulative irritation.
    Dosik J; Ellman H; Stuart I
    J Immunotoxicol; 2019 Dec; 16(1):133-139. PubMed ID: 31179779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady EA; Popescu C; Newton J; Li Wan Po A
    Cochrane Database Syst Rev; 2000; (2):CD002086. PubMed ID: 10796856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline foam (Amzeeq) for acne.
    Med Lett Drugs Ther; 2020 May; 62(1597):68-70. PubMed ID: 32555112
    [No Abstract]   [Full Text] [Related]  

  • 16. Formulation and Profile of FMX101 4% Minocycline Topical Foam for the Treatment of Acne Vulgaris.
    Kircik L; Del Rosso JQ; Weiss JS; Stakias V; London A; Keynan R; Hazot Y; Elliott R; Stuart I
    J Clin Aesthet Dermatol; 2020 Apr; 13(4):14-21. PubMed ID: 33144907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the efficacy and safety of lymecycline and minocycline in patients with moderately severe acne vulgaris.
    Grosshans E; Belaïch S; Meynadier J; Alirezai M; Thomas L
    Eur J Dermatol; 1998; 8(3):161-6. PubMed ID: 9649660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical minocycline foam for moderate to severe acne vulgaris: Phase 2 randomized double-blind, vehicle-controlled study results.
    Shemer A; Shiri J; Mashiah J; Farhi R; Gupta AK
    J Am Acad Dermatol; 2016 Jun; 74(6):1251-2. PubMed ID: 27185426
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
    Leyden J; Thiboutot DM; Shalita AR; Webster G; Washenik K; Strober BE; Shupack J
    Arch Dermatol; 2006 May; 142(5):605-12. PubMed ID: 16702498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.
    Alexis A; Del Rosso JQ; Desai SR; Downie JB; Draelos ZD; Feser C; Forconi R; Fowler JF; Gold M; Kaufman-Janette J; Lain E; Lee M; Ling M; Shamban AT; Werschler WP; Daniels A
    J Clin Aesthet Dermatol; 2018 Nov; 11(11):25-35. PubMed ID: 30588271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.